LABORATORY NEWS
-
Waters Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System, Enabling Broader Access To Bloodstream Infection Diagnostics
Waters Corporation (NYSE: WAT) today announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
- Zepto Life Technology Receives FDA Breakthrough Device Designation For Targeted Liquid Biopsy Test For Invasive Mold Infections
- SGS Expands Bioanalytical Testing Capabilities In North America With Acquisition Of CMIC, INC.
- Co-Diagnostics And CoSara Advance Ebola PCR Test Development And Co-Dx™ PCR Point-Of-Care Platform Capabilities
- CirrusDx Now Offers Susceptibility Testing For Blujepa® (gepotidacin), A Recently Approved Antibiotic For Urinary Tract Infections
ARCHIVED NEWSLETTER
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?